Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
European Journal of Medicinal Chemistry|October 11, 2016
Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregationDawid Panek, Anna Więckowska, Tomasz Wichur, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|October 23, 2020
Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer's diseaseNatalia Szałaj, Justyna Godyń, Jakub Jończyk, et al.Bioorganic & Medicinal Chemistry|January 14, 2014
Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agentsSohail Anjum Shahzad, Muhammad Yar, Marek Bajda, et al.Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Guanidines: Synthesis of Novel Histamine H3R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory EffectMarek Staszewski, Magdalena Iwan, Tobias Werner, et al.International Journal of Molecular Sciences|May 30, 2020
New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's DiseaseKamila Czarnecka, Małgorzata Girek, Przemysław Wójtowicz, et al.ACS Chemical Neuroscience|August 4, 2021
Novel Functionalized Amino Acids as Inhibitors of GABA Transporters with Analgesic ActivityBeata Gryzło, Paula Zaręba, Katarzyna Malawska, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 11, 2023
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's diseaseKamila Czarnecka, Małgorzata Girek, Paweł Kręcisz, et al.Letters in Drug Design & Discovery|April 11, 2014
Design and Synthesis of New Dual Binding Site Cholinesterase Inhibitors: in vitro Inhibition Studies with in silico DockingMuhammad Yar, Marek Bajda, Rana Atif Mehmood, et al.Molecules (Basel, Switzerland)|July 2, 2021
Biphenylalkoxyamine Derivatives-Histamine H3 Receptor Ligands with Butyrylcholinesterase Inhibitory ActivityDorota Łażewska, Paula Zaręba, Justyna Godyń, et al.Frontiers in Aging Neuroscience|December 23, 2022
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeuticsZofia Chrienova, David Rysanek, Patrik Oleksak, et al.Pageof 11